Search Results

Site Search

Neuro-oncology - Insights

Learn how our pediatric neuro-oncology testing includes both comprehensive MayoComplete next-generation sequencing and chromosomal microarray.

Panel offers proactive drug monitoring for IBD: Maria Willrich, Ph.D., and Melissa Snyder, Ph.D. - Insights

Maria Willrich, Ph.D., and Melissa Snyder, Ph.D., describe Mayo Clinic Laboratories' panel for proactive therapeutic drug monitoring of patients with inflammatory bowel disease. The panel expands options for clinicians assessing patients'...

Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D. - Insights

Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' updated ALDG2 assay helps with the evaluation of patients with suspected autoimmune liver disease. The panel also helps with the evaluation of liver disease of unknown etiology.

Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D. - Insights

David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the syndrome, which severely...

Chronic lymphocytic leukemia - Insights

Learn how we increase the quality of care by performing all of our chronic lymphocytic leukemia testing at a single facility.

Medlab Middle East - Insights

Mayo Clinic Laboratories’ menu of advanced diagnostic testing provides insights and answers for the world’s most rare and complex conditions. As the global reference laboratory for Mayo Clinic, we harness the expertise of researchers and...

Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 24 - Insights

This week’s Research Roundup highlights the limitations of platform assays to measure serum 25OHD level impact on guidelines and practice decision-making.

Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 22 - Insights

This week’s Research Roundup highlights neoantigenic potential of complex chromosomal rearrangements in mesothelioma.

Leveraging the Laboratory: Seize Tomorrow - Insights

Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.

Operational updates - Insights

The latest operational updates from Mayo Clinic Laboratories, including holiday shipping schedules, information technology changes, and more.